HIV Is a Major Contributor to Increase in Anal Cancer among U.S. Men

Increased incidence of anal cancer during the past 3 decades among men in the U.S. has been strongly influenced by the HIV epidemic, although a similar association was not observed for women, researchers reported in the October 5, 2012, advance edition of the Journal of the National Cancer Institute. alt

Read more:

ICAAC 2012: Progression of Anal Neoplasia is Common among Gay Men with HIV

Nearly 40% of HIV positive men with low-grade anal neoplasia may progress to high-grade neoplasia or anal cancer, according to a Spanish study presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) this week in San Francisco. Younger age and shorter duration of HIV infection were risk factors for worsening disease.alt

Read more:

HIV Infection Associated with Increased Risk of Lung Cancer and Other non-AIDS Malignancies

HIV positive people have about a 70% higher rate of lung cancer compared with a similar HIV negative population, according to a U.S. veterans study described in the May 15, 2012, issue of AIDS. Related studies of cancer risk presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in March also saw higher rates of non-AIDS malignancies among people with HIV.alt

Read more:

ASCO 2012: Breast Cancer Outcomes among HIV Positive Women

Women with HIV can do well on a variety of different types of treatment for breast cancer, but they are prone to infections and blood cell deficiencies and may benefit from adjunct therapies, researchers reported at the American Society of Clinical Oncology Annual Meeting (ASCO 2012) taking place this week in Chicago.


Read more:

CROI 2012: Electrocautery Superior to Imiquimod or 5-Fluorouracil for Treatment of Anal Neoplasia

Electrocautery was shown to be more effective and tolerable than topical imiquimod or 5-fluorouracil as a treatment for anal intraepithelial neoplasia (AIN) in HIV positive men who have sex with men (MSM), researchers reported in a late-breaker presentation at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last week in Seattle.alt

Read more: